Dual antiplatelet therapy is a combination of aspirin and an oral platelet P2Y12 inhibitor following any stent implantation. It is administered to reduce the risk of thrombosis and prevent failure of the procedure. The duration of this treatment has always been a question of research. However, it has evolved with advanced platelet inhibitors, drug-eluting stents, and new-generation devices. The new generation of stents and devices is associated with lesser or no risks of failure.
In addition, these devices, like the paclitaxel-coated devices, show promising outcomes and require a shorter duration of DAPT following stenting. To know more about these new generation devices and DAPT, join our exclusive session with a reputed interventional cardiologist, Dr. Kavita Tyagi , on 28 th April 2023, 6:00 PM IST onwards! Stay Tuned!
